GLP-1 COMPARISON
Hims vs Mochi Health (2026):
FDA-Approved Drugs vs. Flat-Rate Value
Hims is the only platform offering FDA-approved Wegovy and Zepbound at below-retail prices. Mochi Health offers the lowest flat-rate compounded GLP-1 pricing in the market. They are built for completely different patients — here is how to decide which one is right for you.
By The Dose Report Editorial Team | Updated May 2026 | 10 min read
Hims and Mochi Health are two of the most searched GLP-1 telehealth platforms — and they represent opposite ends of the market. Hims is a premium brand-name platform that offers FDA-approved Wegovy and Zepbound at prices significantly below the pharmacy retail rate, with a mandatory $149/month membership fee. Mochi Health is the value champion: flat-rate compounded semaglutide at $99/month and tirzepatide at $199/month, with no membership fee and no price increases at higher doses. If you want a personalised recommendation based on your state and budget, take our free 2-minute quiz here.
Not Sure Which Is Right for You? You can also use personalised GLP-1 recommendations to get a personalised recommendation based on your state and budget.
Take Our Free GLP-1 Matching Quiz
Answer 10 quick questions about your state, budget, and goals. We’ll match you with the program that fits — comparing Hims, Mochi Health, and 11 other programs.
The One-Minute Summary
Hims
FDA-Approved Drugs at Below-Retail Prices
Offers Wegovy and Zepbound (brand-name, FDA-approved) plus compounded options. Mandatory $149/mo membership fee. Best for men who want the brand-name drug or who have insurance that covers Hims.
Choose Hims If
You specifically want FDA-approved Wegovy or Zepbound, are a man, and the $149/mo membership fee fits your budget
Mochi Health
Lowest Flat-Rate Pricing in the Market
$99/mo semaglutide, $199/mo tirzepatide — flat rate at every dose. No membership fee. Insurance concierge and dietitian access included. Open to all genders.
Choose Mochi Health If
You want the lowest ongoing cost, are comfortable with compounded medication, and do not need the brand-name drug specifically
Side-by-Side Comparison
Prices approximate and subject to change. Always verify directly with each provider.
The True Cost: Why the Membership Fee Changes Everything
The single most important thing to understand about Hims is that the medication price you see advertised is not what you actually pay. Hims charges a mandatory $149/month membership fee on top of the medication cost. This fundamentally changes the cost comparison with Mochi Health.
Hims True Monthly Cost
- Compounded semaglutide: $149/mo medication + $149/mo membership = ~$298/mo true total
- Compounded tirzepatide: $299–$399/mo medication + $149/mo membership = ~$448–$548/mo true total
- Wegovy (brand-name): Significantly discounted from $1,300 retail, but still requires the membership fee
Mochi Health True Monthly Cost
- Compounded semaglutide: $99/mo medication + $79/mo membership = $178/mo true total
- Compounded tirzepatide: $199/mo medication + $79/mo membership = $278/mo true total
At the semaglutide level, Mochi Health is approximately $120/month cheaper than Hims on an ongoing basis. Over 12 months, that is $1,440 in savings. The gap is even larger for tirzepatide.
The only scenario where Hims becomes cost-competitive is if you specifically want FDA-approved Wegovy or Zepbound — which Mochi Health does not offer. At that level, Hims’ below-retail brand-name pricing may be the cheapest available option for brand-name drugs.
Hims — Check Eligibility
FDA-approved Wegovy and Zepbound available. Compounded options from $149/mo + $149/mo membership. Men only.
Mochi Health — Check Eligibility
$99/mo semaglutide, $199/mo tirzepatide. Flat rate at all doses. Insurance concierge + dietitian included.
Where Hims Has a Clear Advantage
FDA-Approved Brand-Name Drugs
Hims is one of the very few telehealth platforms offering FDA-approved Wegovy and Zepbound at below-retail prices. For patients who specifically want the brand-name drug — whether for regulatory certainty, insurance billing purposes, or personal preference — Hims is one of the most accessible options available. Mochi Health offers compounded medications only.
The Novo Nordisk Lawsuit Context
In 2025, Novo Nordisk filed lawsuits against several compounded GLP-1 platforms. Hims, which offers both compounded and brand-name options, has navigated this more carefully than pure compounding platforms. Patients who are concerned about the regulatory future of compounded GLP-1s may prefer Hims’ brand-name pathway.
Men’s Health Ecosystem
Hims is a men’s health platform with a broader ecosystem including hair loss, ED treatment, and skincare. For men who want to manage multiple health concerns through a single platform, Hims offers more breadth than Mochi Health. Our full Hims review covers the complete picture.
Where Mochi Health Has a Clear Advantage
Price: The Biggest Gap
At $178/month true total for semaglutide versus Hims’ $298/month, Mochi Health is approximately 40% cheaper on an ongoing basis. For a 12-month treatment course, that is a $1,440 difference. The flat-rate pricing that never increases with dose is an additional advantage — Hims’ tirzepatide pricing escalates significantly at higher doses.
Insurance Concierge
Mochi Health includes an insurance concierge service that helps patients navigate coverage for their GLP-1 prescription. This is genuinely valuable — as we covered in our insurance coverage guide, some employer plans do cover GLP-1 medications, and Mochi Health’s concierge can help you find out if yours does. Hims does not offer this service.
Dietitian Access
Mochi Health includes access to a registered dietitian as part of the membership. For patients who want nutritional guidance alongside their GLP-1 treatment, this adds meaningful value. Hims does not include dietitian access.
Gender Inclusivity
Mochi Health serves all genders. Hims is men-only — women need to use Hers, which is a separate platform with a separate enrollment process. If you are a woman comparing these two options, the relevant comparison is Hers vs Mochi Health rather than Hims.
Who Should Choose Each Platform
Choose Hims If:
- You are a man who specifically wants FDA-approved Wegovy or Zepbound rather than compounded medication
- You have insurance that covers Hims’ brand-name drugs and want to use it
- You want a men’s health platform that covers multiple conditions beyond weight loss
- You are concerned about the regulatory future of compounded GLP-1s and prefer the brand-name pathway
Choose Mochi Health If:
- You want the lowest ongoing monthly cost — Mochi Health is approximately 40% cheaper than Hims for semaglutide
- You are comfortable with compounded medication from a licensed U.S. pharmacy
- You want a flat rate that never increases as your dose escalates
- You want insurance concierge help or dietitian access included in your membership
- You are a woman — Mochi Health serves all genders while Hims is men-only
If neither platform feels like the right fit, Yucca Health at $146/month on a 6-month plan and SkinnyRx are both worth considering as alternatives.
Our Verdict
For most patients comparing Hims and Mochi Health, Mochi Health wins on value. The true total cost is approximately 40% lower, the flat-rate pricing is more predictable, and the insurance concierge and dietitian access add genuine value that Hims does not match.
Hims wins in one specific scenario: if you want FDA-approved Wegovy or Zepbound at below-retail prices. That is a real differentiator that no compounding-only platform can match. If brand-name medication is important to you — for regulatory certainty, insurance billing, or personal preference — Hims is worth the premium.
For everyone else, Mochi Health is the stronger choice at this price point.
Frequently Asked Questions
Is Hims or Mochi Health cheaper?
Mochi Health is significantly cheaper on an ongoing basis. Mochi Health’s true total cost is $178/month for semaglutide ($99 medication + $79 membership). Hims’ true total is approximately $298/month ($149 medication + $149 membership). Over 12 months, Mochi Health saves approximately $1,440.
Does Hims offer FDA-approved Wegovy?
Yes. Hims is one of the few telehealth platforms offering FDA-approved Wegovy and Zepbound at below-retail prices. Mochi Health offers compounded medications only.
Can women use Hims for weight loss?
No. Hims is a men-only platform. Women should use Hers (the sister platform) or Mochi Health, which serves all genders.
Does Mochi Health’s price increase with my dose?
No. Mochi Health’s flat-rate pricing ($99/mo semaglutide, $199/mo tirzepatide) applies at all dose levels. Hims’ tirzepatide pricing escalates at higher doses.
What is Mochi Health’s insurance concierge?
Mochi Health includes a service that helps patients navigate whether their insurance plan covers GLP-1 medications. Some employer plans do cover GLP-1s, and Mochi’s concierge can help you find out and submit the necessary documentation. Hims does not offer this service.
Still Deciding?
Take Our Free GLP-1 Matching Quiz
Answer 10 quick questions about your state, budget, and goals. We’ll match you with the program that fits — comparing Hims, Mochi Health, and 11 other options.
Affiliate Disclosure: Some links on this page may earn us a commission at no extra cost to you. This does not affect our editorial opinion.
Your independent source for GLP-1 and weight loss product reviews, news, and expert tips.
QUICK LINKS
Affiliate Disclosure: TheDoseReport.com participates in affiliate programs. Some links on this site may earn us a commission at no extra cost to you. This does not influence our editorial content. All reviews and opinions are our own.
Medical Disclaimer: This website does not provide medical advice. All content is for informational purposes only. Always consult a qualified healthcare professional before starting any weight loss program or medication.